NIAID Workshop, Memphis, Tennessee, 25-26 March 1997: Statistical issues for HIV surrogate endpoints: Point/counterpoint

Statistics in Medicine

Volumn 17, Issue 21, 1998, Pages 2435-2462

  Albert, Jeffrey M ^a,n   Ioannidis, John P A ^a   Reichelderfer, Patricia ^a   Conway, Brian ^b   Coombs, Robert W ^c   Crane, Lawrence ^d   Demasi, Ralph ^e   Dixon, Dennis O ^a   Flandre, Phillipe ^f   Hughes, Michael D ^g   Kalish, Leslie A ^h   Larntz, Kinley ⁱ   Lin, Danyu ^c   Marschner, Ian C ^j   Muñoz, Alvaro ^k   Murray, Jeff ^l   Neaton, Jim ⁱ   Pettinelli, Carla ^a   Rida, Wasima ^a   Taylor, Jeremy M G ^m   Welles, Seth L ⁱ   more..

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF WASHINGTON   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e Glaxo Wellcome

^f Inst Natl S et de la Rech Med

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h NEW ENGLAND RESEARCH INSTITUTES   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

^j HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^k JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^l CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VIRUS RNA; BIOLOGICAL MARKER;

CLINICAL STUDY; CONFERENCE PAPER; DISEASE COURSE; DISEASE MARKER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; OUTCOMES RESEARCH; PATIENT CARE; PROGNOSIS; STATISTICAL ANALYSIS; STATISTICS; WORKSHOP; ARTICLE; CD4 LYMPHOCYTE COUNT; GENETICS; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; HIV; HIV INFECTIONS; HUMANS; MODELS, STATISTICAL; PROPORTIONAL HAZARDS MODELS; RNA, VIRAL; STATISTICS; TREATMENT OUTCOME;

EID: 0032533023     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19981115)17:21<2435::AID-SIM994>3.0.CO;2-G     Document Type: Conference Paper

References (71)

1. Taylor, J. M. G., Fahey, J. L., Detels, R. and Giorgi, J. V. 'CD4 percentage, CD4 number and CD4: CD8 ratio in HIV infection: Which to choose and how to use', Journal of Acquired Immune Deficiency Syndromes, 2, 114-124 (1989).
2. Malone, J. L., Simms, T. E., Gray, C. G., Wagner, R. F., Burge, J. R. and Burke, D. S. 'Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: Total lymphocyte count fluctuations and diurnal cycle are important', Journal of Acquired Immune Deficiency Syndromes, 3, 144-151 (1990).
3. Prentice, R. L. 'Surrogate endpoints in clinical trials: definitions and operational criteria', Statistics in Medicine, 8, 431-440 (1989).
4. Vandamme, A. M., Schmit, J. C., Van Dooren, S., Van Laethem, K., Grobbers, E., Kok, W., Goubau, P., Witrouw, M., Peetermans, W., DeClerq, E. and Desmyter, J. 'Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor kit', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 13, 127-139 (1996).
5. Kalbfleisch, J. D. and Prentice, R. L. The Statistical Analysis of Failure Time Data, Wiley, New York, 1980.
6. Ioannidis, J. P. A., Cappelleri, J. C., Sacks, H. S. and Lau, J. 'The relationship between study design, results and reporting in randomized trials of HIV infection', Controlled Clinical Trials, 18, 431-444 (1997).
7. Hogan, C. H., Hodges, J. S., Mugglin, A., Peterson, P. M., Abrams, D. and Saravolatz, L. 'The perils of visit-driven endpoints in antiretroviral trials'. In: Abstracts of the XI International Conference on AIDS, Vancouver, Canada, July 7-12, 1996 (abstract TUB.522).
8. Choi, S., Lagakos, S. W., Schooley, R. T., and Volberding, P. A. 'CD4 + lymphocytes are an incomplete surrogate marker for clinical disease progression in persons with asymptomatic HIV infection', Annals of Internal Medicine, 118, 674-680 (1993).
9. Babiker, A. for the Delta Co-ordinating Committee and Virological Group. 'Can HIV-1 RNA viral load be used as a surrogate for clinical outcome in HIV disease?', 6th European conference on Clinical Aspects and Treatment of HIV Infection, Hamburg, Germany, 11-15 October 1997 (Abstract 103).
10. O'Quigley, J. and Flandre, P. 'Predictive capability of proportional hazards regression', Proceedings of the National Academy of Sciences of the United States of America, 91, 2310-2314 (1994).
11. Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A. and Kingsley, L. A. 'Prognosis of HIV-1 infection predicted by the quantity of virus in plasma', Science, 272, 1167-1170 (1996).
12. Henrard, D. R., Phillips, J. F., Muenz, L. R., Blattner, W. A., Wiesner, D., Eyster, M. E. and Goedert, J. J. 'Natural history of HIV-1 cell-free viremia', Journal of the American Medical Association, 274, 554-558 (1995).
13. Phillips, A. N., Eron, J. J., Bartlett, J. A., Rubin, M., Johnson, J., Price, S., Self, P. and Hill, A. M. 'HIV-1 RNA levels and the development of clinical disease', AIDS, 10, 859-865 (1996).
14. Kuhn, A. M. and DeMasi, R. A. 'Empirical power for tests on longitudinal data with non-informative missingness with applications to AIDS trials', Presentation at the International Biometric Society Eastern North American Region Meetings, Memphis, TN, March, 1997.
15. Raboud, J. M., Montaner, J. S., Conway, B., Maley, L., Sherlock, C., O'Shaughnessy, M. V. and Schlechter, M. T. 'Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection', Journal of Infectious Diseases, 174, 191-194 (1996).
16. Ho, D. D. 'Viral counts count in HIV infection', Science, 272, 1124-1125 (1996).
17. Mellors, J. W., Kingsley, L. A., Rinaldo, C. R., Todd, J. A., Hoo, B. S., Kokka, R. P. and Gupta, P. 'Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion', Annals of Internal Medicine, 122, 573-579 (1995).
18. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. and Markowitz, M. 'Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infections', Nature, 373, 123-126 (1995).
19. Hamilton, J. D., Hartigan, P. M., Simberkoff, M. S., Day, P., Diamond, G., Dickinson, G., Dursano, G., Egorin, M., George, W., Gordin, F., Hawkes, C., Jensen, P., Klimas, N., Labriola, A., Lahart, C., O'Brien, W., Oster, C., Weinhold, K., Wray, N., Zolla-Pazner, S. and the Veterans Affairs Cooperative Study Group on AIDS treatment. 'A controlled trial of early versus late treatment with Zidovudine in symptomatic HIV infection', New England Journal of Medicine, 326, 437-443 (1992).
20. O'Brien, W. A., Hartigan, P. M., Martin, D., Esinhart, J., Hill, A., Benoit, S., Rubin, M., Simberkoff, M. F., and Hamilton, J. D. 'Changes in Plasma HIV-1 RNA and CD4 + lymphocyte counts and the risk of progression to AIDS', New England Journal of Medicine, 334, 426-431 (1996).
21. Paxton, W. B., Coombs, R. W., McElrath, M. J., Keefer, M. C., Hughes J., Sinangil, F., Chernoff, D., Demeter, L., Williams, B. and Corey, L. 'Longitudinal analysis of quantitative virologic measures in HIV infected subjects with <400 CD4 lymphocytes: implications for applying measurements to individual patients', Journal of Infectious Diseases, 175, 247-254 (1997).
22. Shi, M., Taylor, J. M. G. and Muñoz, A. 'Models for residual time to AIDS', Lifetime Data Analysis, 2, 31-49 (1996).
23. Giorgi, J. V., Liu, Z., Hultin, L.E., Cumberland, W. G., Hennessey, K. and Detels, R. 'Elevated levels of CD38 + CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: Results of 6 years of follow-up', Journal of Acquired Immune Deficiency Syndrome, 6, 904-912 (1993).
24. Shi, M., Currier, R. J., Taylor, J. M. G., Tang, H., Hoover, D. R., Chmiel, J. S. and Bryant, J. 'Replacing time since HIV infection by marker values in predicting residual time to AIDS diagnosis', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12, 309-316 (1996).
25. Yong, F. H. L., Taylor, J. M. G., Bryant, J. L., Chmiel, J. S., Gange, S. J. and Hoover, D. 'Dependence of the hazard of AIDS on markers', AIDS, 11, 217-228 (1997).
26. Shi, M., Taylor, J. M. G., Fahey, J. L., Hoover, D. R., Munoz, A. and Kingsley, L. A. 'Early levels in CD4, neopterin and b2 microglobulin indicate future HIV disease progression', Journal of Clinical Immunology, 17, 43-52 (1997).
27. Ioannidis, J. P. A., Cappelleri, J. C., Lau, J., Sacks, H. S. and Skolnik, P. R. 'Predictive value of viral load measurements in asymptomatic, untreated HIV-infection: a mathematical model', AIDS, 10, 255-262 (1996).
28. Ioannidis, J. P. A., Cappelleri, J. C., Schmid, C. H. and Lau, J. 'Impact of epidemic and individual heterogeneity on the population distibution of disease progression rates. An example from patient populations in trials of human immunodeficiency virus infection', American Journal of Epidemiology, 144, 1074-1085 (1996).
29. Ioannidis, J. P. A., Sacks, H. S., Cappelleri, J. C. and Lau, J. 'Clinical efficacy of antiretroviral changes in treatment-experienced HIV-infected patients. A meta-analysis', Online Journal of Current Clinical Trials, 15 May 1997; Doc No 204 (1997).
30. Havlir, D. V. and Richman, D. D. 'Viral dynamics of human immunodeficiency virus: implications for drug development and therapeutic strategies', Annals of Internal Medicine, 124, 984-994 (1996).
31. Marschner, I. C., Collier, A. C., Coombs, R. W., D'Aquila R. T., DeGruttola, V., Fischl, M. A., Hammer, S. M., Hughes, M. D., Johnson, V. A., Katzenstein, D. A., Richman, D. D., Smeaton, L. M., Spector, S. A. and Saag, M. S. 'The use of changes in plasma levels of human immunodeficiency virus type 1 RNA levels to assess the clinical benefit of antiretroviral therapy', Journal of Infectious Diseases, 177, 40-47 (1998).
32. Hughes, M. D., Johnson, V. A., Hirsch, M. S., Bremer, J. W., Elbeik, T., Erice, A., Kuritzkes, D. R., Scott, W. A., Spector, S. A., Basqoz, N., Fischl, M. A. and D'Aquila R. T. 'Monitoring plasma human immunodeficiency virus (HIV-1) RNA levels in additions to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response', Annals of Internal Medicine, 126, 929-938 (1997).
33. Emini, E. A. 'Resistance to anti-human immunodeficiency virus therapeutic agents', Advances in Experimental Medicine and Biology, 390, 187-195 (1995).
34. Rosenbaum, P. R. 'The consequences of adjustment for a concomitant variable that has been affected by the treatment', Journal of the Royal Statistical Society, Series A, 147, 656-666 (1984).
35. Fleming, T. R. 'Surrogate markers in AIDS and cancer trials', Statistics in Medicine, 13, 1423-1435 (1994).
36. Daniels, M. J. and Hughes, M. D. 'Meta-analysis for the evaluation of potential surrogate markers', Statistics in Medicine, 16, 1965-1982 (1997).
37. De Gruttola, V., Fleming, T. R., Lin, D. Y. and Coombs, R. 'Validating surrogate markers - are we being naive?', Journal of Infectious Diseases, 175, 237-246 (1997).
38. Lin, D. Y., Fleming, T. R. and DeGruttola, V. 'Estimating the proportion of treatment effect explained by a surrogate marker', Statistics in Medicine, 16, 901-910 (1997).
39. Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour. H. H. Jr, Reichman, R. C., Bartlett, J. A., Hirsch, M. S., et al. 'Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter', New England Journal of Medicine, 322, 941-949 (1990).
40. Lin, D. Y., Fischl, M. A. and Schoenfeld, D. A. 'Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials', Statistics in Medicine, 12, 835-842 (1993).
41. Miller, R. G., Jr. Simultaneous Statistical Inference, 2nd edn, Springer-Verlag, New York, 1981.
42. Meinert, C. L. Clinical Trials: Design, Conduct, and Analysis, Oxford Univeristy Press, New York, 1986.
43. Welles, S. L., Jackson, J. B., Yen-Lieberman, B., Demeter, L., Japour, A. J., Smeaton, L. M. Johnson, V. A., Kuritzkes, D. R., D'Aquila, R. T., Reichelderfer, P. A., Richman, D. D., Reichman, R., Fischl, M., Dolin, R., Coombs, R. W., Kahn, J. O., McLaren, C., Todd, J., Kwok, S. and Crumpacker, C. S. for the AIDS Clinical Trials Group Protocol 116A/116B/117 Team. 'Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy', Journal of Infectious Diseases, 174, 696-703 (1996).
44. Chambers, J. M., Cleveland, W. S., Kleiner, B. and Tukey, P. A. Graphical Methods for Data Analysis, Belmont, CA, Wadsworth International Group (Duxbury Press), 1983.
45. Muñoz, A. and Sunyer, J. 'Comparison of semiparametric and parametric survival models for the analysis of bronchial responsiveness', American Journal of Respiratory and Critical Care Medicine, 154, S234-S239 (1996).
46. Mellors, J. W., Muñoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Kingsley, L. A., Todd, J. A., Saah, A. J., Detels, R. R., Phair, J. P. and Rinaldo, C. R., Jr. 'Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection', Annals of Internal Medicine, 126, 946-954 (1997).
47. Yusuf, S., Held, P., Teo, K. K. and Toretsky, E. R. 'Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria', Statistics in Medicine, 9, 73-86 (1990).
48. Saravolatz, L., Neaton, J. D., Sacks, L., Deyton, L., Rhame, F. and Sherer, R. 'CD4+ T lymphocyte counts and patterns of mortality among patients infected with human immunodeficiency virus who were enrolled in Community Programs for Clinical Research on AIDS', Clinical Infectious Diseases, 22, 513-520 (1996).
49. Kozal, M. J., Shafer, R. W., Winters, M. A., Katzenstein, D. A., Aquiniga, E., Halpem, J. and Merigan, T. C. 'HIV-1 syncytium inducing phenotype, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients', Journal of Acquired Immune Deficiency Syndromes, 7, 832-838 (1994).
50. Holodnyi, M., Katzenstein, D., Mole, L., Winters, M. and Merigan, T. 'HIV reverse transcriptase codon 215 mutations diminish virologic response to didanosine-zidovudine treatment in subjects with non-syncytium inducing phenotype', Journal of Infectious Diseases, 174, 854-857 (1996).
51. Dean, M., Carrington, M., Winkler, C., Hutley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghof, E., Gomperts, E., Donfield, S., Vlahov, D., Kalsow, R., Saah, A., Rinaldo, C., Detels, R. and O'Brien, S. J. 'Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene', Science, 273, 1856-1862 (1996).
52. Mocroft, A., Johnson, M. A. and Phillips, A. N. 'Factors affecting survival in patients with the acquired immune deficiency syndrome' [editorial], AIDS, 10, 1057-1065 (1996).
53. Wong, J. K., Gunthard, H.F., Havlir, D. V., Haase, A. T., Zhang, Z. Q., Kwok, S., Ignacio, C.C., Keating, N. A., Chodakewitz, J., Emini, E., Meibohm, A., Jonas, L. and Richman, D. D. 'Reduction of HIV blood and lymph nodes after potent antiretroviral therapy', Presentation at 4th Conference on Retroviruses and Opportunistic Infections, 22-26 January 1997.
54. Freedman, L. S., Graubard, B. L. and Schatzkin, A. 'Statistical validation of intermediate endpoints for chronic diseases', Statistics in Medicine, 11, 167-178 (1993).
55. Fleming, T. R. and DeMets, D. L. 'Surrogate endpoints in clinical trials: are we being misled?', Annals of Internal Medicine, 125, 605-613 (1996).
56. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. 'Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction', New England Journal of Medicine, 321, 406-412 (1989).
57. Sperling, R. S., Shapiro, D. E., Coombs, R. W., Todd, J. A., Herman, S. A., McSherry, G. D., O'Sullivan, M. J., VanDyke, R. B., Jimenez, E., Rouzioux, C., Flynn, P. M. and Sullivan, J. L. 'Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant', New England Journal of Medicine, 335, 1621-1629 (1996).
58. DeGrutolla, V., Wulfsohn, M., Fischl, M. A. and Tsiatis, A. 'Modeling the relationship between survival and CD4 lymphocytes inpatients with AIDS and AIDS related complex', Journal of Acquired Immune Deficiency Syndromes, 6, 359-365 (1993).
59. Tsiatis, A. A., DeGruttola, V. and Wulfsohn, M. 'Modeling the relationship of survival to longitudinal data measured with error. Applications to survival and CD4 counts in patients with AIDS', Journal of the American Statistical Association, 90, 27-37 (1995).
60. Gulick, R., Mellors, J., Havlir, D., Eron, J., Gonzalez, C., McMahon, D., Richman, D., Valentine, F., Jonas, L., Meibohm, A., Chiou, R., Deutsch, P., Emini, E. and Chodakewitz, J. 'Potent and sustained antiretroviral activity of indinavir in combination with zidovudine and lamivudine', In: Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections, Washington, D.C., 28 January to 1 February 1996 (abstract LB7).
61. Markowitz, M., Cao, Y., Vesanen, M., Tala, A., Nixon, D., Hurley, A., O'Donovan, R., Racz, P., Tenner-Racz, K. and Ho, D.D. 'Recent HIV infection treated with AZT,3TC, and a potent protease inhibitor', In: Abstracts of the 4th conference on Retroviruses and Opportunistic Infections, Washington, D.C., 22-26 January 1997 (abstract LB8).
62. Pantaleo, G., Menzo, S., Vaccarezza, M., Graziosi, C., Cohen, O. J., Demarest, J. F., Montefiori D., Orenstein, J. M., Fox, C., Schrager, L. K. et al. 'Studies in subjects with long-term non-progressive human immunodeficiency virus infection', New England Journal of Medicine, 332, 209-216 (1995).
63. Peters, B. S., Coleman, D. G., McGuiness, O., Pinching, A. J., Wadsworth, M. J., and Harris, J. R. 'Changing disease patterns in patients with AIDS in a referral center in the United Kingdom: the changing face of AIDS', British Medical Journal, 302, 203-207 (1991).
64. Lederman, M., Connick, E., Landay, A., Kessler, H., Kuritzkes, D., Rousseau, F. and Spritzler, J. 'Partial immune reconstitution after 12 weeks of HAART. Preliminary results of ACTG315', In: Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, D.C., 22-26 January 1997 (abstract LB13).
65. Phillips, P., Zala, C., Rouleau, D. and Montaner, J. S. 'Mycobacterial lymphadenitis: can highly active antiretroviral therapy unmask subclinical infection?' In: abstracts of the 4th National Conference on Retroviruses and Opportunistic Infections, Washington, DC, 22-26 January 1997 (abstract 351).
66. Race, E., Adelson-Mitty, J., Barlam, T. and Japour, A. 'Focal inflammatory lymphadenitis (FIL) and fever following initiation of protease inhibitor in patients with advanced HIV-1 disease' In: Abstracts of the 4th National Conference on Retroviruses and Opportunistic Infections, Washington, DC, 22-26 January 1997.
67. Katzenstein, D. A., Hammer, S. H., Hughes, M. D., Gundacker, H., Jackson, J. B., Fiscus, S., Rasheed, S., Elbeik, T., Reichman, R., Japour, A., Merigan, T. C. and Hirsch, M. S. 'The relationship of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter', New England Journal of Medicine, 335, 1091-1098 (1996).
68. Kleinbaum, D. G., Kupper, L. L. and Morganstern, H. Epidemiologic Research: Principles and Quantitative Methods, Van Nostrand Reinhold, New York, 1982.
69. Conway, B., Montaner, J. S. B., Cooper, D., Vella, S., Reiss, P., Lange, J., Harris, M., Wainberg, M., Kwok, S., Sninsky, J., Hall, D., Myers, M. and the INCAS study group. 'Randomized double-blind one year study of the immunologic and virologic effects of nevirapine, didanosine and zidovudine combinations among antiretroviral naïve AIDS-free patients with CD4 200-600', AIDS, 10, S15 (1996).
70. Mulder, J., Resnick, R., Saget, B., Scheibel, S., Herman, S., Payne, H., Harrigan, R., and Kwok, S. 'A rapid and simple method for extracting human immunodeficiency virus type 1 from plasma: enhanced sensitivity', Journal of Clinical Microbiology, 35, 1278-1280 (1997).
71. Conway, B., Shillington, A., Fransen, S., Sninsky, J., Kwok, S. and Montaner, J. S. G. 'Application of Ultra-Sensitive PCR to the analysis of plasma viral load testing in clinical trials', In: Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, D.C., 22-26 January 1997 (abstract 629).